Evidence map›Paper›PMID 42330956›Full record

ArticleNeuron2026

Objective quality assessment for precision functional MRI data.

Charles J Lynch, Megan Chang, Immanuel Elbau, Evan M Gordon, Timothy O Laumann, Jingnan Du, Zach Ladwig, Maximilian Lueckel, Diana C Perez, Indira Summerville and 26 more

Abstract read
In one paragraph

Article in Neuron, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors.

Charles J LynchDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: cjl2007@med.cornell.edu.
Megan ChangDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Immanuel ElbauDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Evan M GordonDepartment of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Timothy O LaumannDepartment of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Jingnan DuDepartment of Psychology, Center for Brain Science, Harvard University, Cambridge, MA 02138, USA.
Zach LadwigDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Maximilian LueckelLeibniz Institute for Resilience Research, 55122 Mainz, Germany; Neuroimaging Center, Focus Program Translational Neurosciences, Johannes Gutenberg University Medical Center, Mainz, Germany.
Diana C PerezDepartment of Psychology, Northwestern University, Evanston, IL 60208, USA.
Indira SummervilleDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Jolene ChouDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Megan JohnsonDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Claire HoDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Nicola ManfrediDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Parsa NilchianDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Nili SolomonovDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Eric GoldwaserDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Tommy NgDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Stefano MoiaFaculty of Psychology and Neuroscience, Department of Psychology and Neuroscience, Maastricht University, 6229 ER Maastricht, the Netherlands.
Cesar Caballero-GaudesBasque Center on Cognition, Brain and Language, Donostia-San Sebastián, Gipuzkoa 20009, Spain.
Jonathan DownarDepartment of Psychiatry, Institute of Medical Science, University of Toronto, Toronto, ON M5T 1R8, Canada; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, Canada; Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, Canada.
Fidel Vila-RodriguezDepartment of Psychiatry, University of British Columbia, Vancouver, BC V6T 2A1, Canada.
Elizabeth GregoryDepartment of Psychiatry, University of British Columbia, Vancouver, BC V6T 2A1, Canada.
Zafiris J DaskalakisDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093, USA.
Daniel M BlumbergerDepartment of Psychiatry, Institute of Medical Science, University of Toronto, Toronto, ON M5T 1R8, Canada; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, Canada; Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, Canada.
Kendrick KayCenter for Magnetic Resonance Research, University of Minnesota, Minneapolis, MN 55455, USA.
Derrick M BuchananDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
Nolan WilliamsDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
Mahendra T BhatiDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jacqueline ClaussMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Catonsville, MD 21228, USA.
Benjamin ZebleyDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Lindsay W VictoriaDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Jonathan D PowerDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Logan GrosenickDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Faith M GunningDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Conor ListonDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: col2004@med.cornell.edu.

Funding

Efficacy of biomarker-guided rTMS for treatment resistant depressionR01MH118388 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI BHATI, MAHENDRA T, GUNNING, FAITH M · 2019 to 2025
$6.2M
Positive valence systems engagement during social reward exposure psychotherapy for mid- and late-life depressionK23MH123864 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI SOLOMONOV, NILI · 2020 to 2024
$954k
NIMH NIH HHS K23 MH123864NIMH NIH HHS R01 MH118388
6 · The paper itself

Abstract

Precision functional mapping (PFM) enables the individual-level characterization of brain network organization but requires substantially more and higher-quality fMRI data than is standard. Despite the growing use of PFM, the objective criteria for data sufficiency and the quality needed to ensure interpretable and replicable individual-level results remain unclear. Here, we introduce the network similarity index (NSI), an objective measure of the extent to which functional connectivity (FC) patterns express the large-scale network structure required for PFM. The NSI captures low-spatial-frequency, coherent network organization and denoising fidelity, and it aligns closely with blinded expert assessments of PFM usability. The NSI also accounts for the variability in the rate at which FC becomes reliable across individuals. This NeuroResource provides an open source framework for NSI-based data quality evaluation and models linking NSI values with expert-judged PFM suitability. This framework can inform expected returns from additional data collection, thus enabling principled decisions about data sufficiency and replication in precision fMRI research.

Indexed as

data qualityfunctional connectivityindividual-specific networksmulti-echo fMRInetwork similarity indexprecision functional mappingquality controlresting-state fMRItest-retest reliability

Identifiers

PMID42330956
PMCPMC13288760

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.